Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Research Reports
    3. >Contrast Media Injectors Market is estimated to account for US$ 2,000.7 Mn in terms of value and 49,381 units in terms of volume by the end of 2027.
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Research Reports

    Contrast Media Injectors Market Is Estimated to Account for Us$ 2,000.7 Mn in Terms of Value and 49,381 Units in Terms of Volume by the End of 2027.

    Published by Coherent Market Insights

    Posted on September 16, 2021

    4 min read

    Last updated: February 9, 2026

    Add as preferred source on Google
    This image illustrates the significant market value loss of Siemens Energy and Siemens Gamesa following a profit warning, highlighting challenges in the wind turbine industry amid rising costs.
    Siemens Energy faces $5 billion loss due to Siemens Gamesa profit warning - Global Banking & Finance Review
    Tags:technologyhealthcarefinancial servicesinvestment

    Contrast Media Injectors Market is estimated to account for US$ 2,000.7 Mn in...

    Contrast Media Injectors Market – Competitive Landscape

    Key players functioning in the global prosthetic liners market consists of Lonza Group Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies, and American Type Culture Collection (ATCC) Inc.

    Contrast media injectors allow for the injection of contrast media into targeted areas within the body. The use of these media allows for the creation of detailed imaging scans that easily distinguish one section of tissue from the other. Technology has also become a valuable tool in the treatment of many degenerative diseases, especially those that affect the nervous system. This particular form of therapy is especially effective in combating the adverse effects of multiple sclerosis.

    Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/3157

    The introduction of contrast media injectors into radiology has created a more complete method of examining the human body. This medical equipment allows for the study of the nervous system as well as the brain at the same time. The process through which this medical technology is used is highly complicated, as is the information that must be provided to the patient before beginning the procedure. For this reason, most private medical practitioners have opted to outsource the work to medical companies that specialize in the study of contrast media injectors. This outsourcing allows for more sophisticated technology to be utilized in the examination of patients.

    The rising prevalence of cancer all across the globe is boosting the growth of the global contrast media injectors market. For instance, according to the World Health Organization (WHO), in 2018, cancer was the leading cause of death in the world, and around 9.6 million deaths were registered that year. Moreover, the rapid increase of investment by various private and government organizations in the treatment and management of severe chronic diseases is also augmenting the growth of the global contrast media injectors market.

    The use of contrast media injectors in the field of medical imaging is nothing new. However, the use of these specialized machines has only been utilized in the past few years. Because of the advanced tools that are now available to radiologists, it has become much easier to perform difficult tasks that were once rendered nearly impossible. The use of a sophisticated medical imaging system such as this creates an opportunity for a radiologist to take a very comprehensive view of a patient’s entire body. However, the cost of the contrast media injectors along with the accessories and consumables is the main factor that is posing as a threat to the growth of the global contrast media injectors market.

    Owing to the incidence rate of cancer in the region, North America is witnessing high growth in the global contrast media injectors market. For instance, according to the National Cancer Institute, in 2019 there around 1,762,450 new diagnosed cases of cancer in the US. Moreover, the presence of key market players in the region is also enhancing the growth of the global contrast media injectors market. Owing to such factors, there have been significant developments in the global contrast media injectors market. For instance, in 2018 Visipaque (iodixanol) developed by General Electric got approved by the US Food and Drug Administration.

    Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3157

    Reasons to Purchase this Report

    • Current and future of global Contrast Media Injectors Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players

    Contact Us

    Mr. Shah
    Coherent Market Insights
    1001 4th Ave, #3200 Seattle, WA 98154, U.S.
    Email: sales@coherentmarketinsights.com
    United States of America: +1-206-701-6702
    United Kingdom: +44-020-8133-4027
    Japan: +050-5539-1737
    India: +91-848-285-0837

    The post Contrast Media Injectors Market is estimated to account for US$ 2,000.7 Mn in terms of value and 49,381 units in terms of volume by the end of 2027. appeared first on Gatorledger.

    Frequently Asked Questions about Contrast Media Injectors Market is estimated to account for US$ 2,000.7 Mn in terms of value and 49,381 units in terms of volume by the end of 2027.

    1What is the estimated value of the contrast media injectors market by 2027?

    The contrast media injectors market is estimated to account for US$ 2,000.7 million in terms of value by the end of 2027.

    2
    Which regions are experiencing high growth in the contrast media injectors market?

    North America is witnessing high growth in the global contrast media injectors market due to the high incidence rate of cancer in the region.

    3What role do contrast media injectors play in medical imaging?

    Contrast media injectors allow for the injection of contrast media into targeted areas within the body, enabling the creation of detailed imaging scans.

    4Who are the key players in the contrast media injectors market?

    Key players in the global contrast media injectors market include Lonza Group Ltd., Merck Millipore Corporation, and Sanofi-Aventis LLC.

    5How has the introduction of contrast media injectors impacted radiology?

    The introduction of contrast media injectors has created a more complete method of examining the human body, enhancing the study of various systems.

    More from Research Reports

    Explore more articles in the Research Reports category

    Image for Workflow Automation Market Outlook 2025: Business Expansion, Market Trends, and Future Predictions
    Workflow Automation Market Outlook 2025: Business Expansion, Market Trends, and Future Predictions
    Image for Smart Contracts Market 2032 Industry Overview, Evolution Growth Rate and Future Forecasts 2025-2032
    Smart Contracts Market 2032 Industry Overview, Evolution Growth Rate and Future Forecasts 2025-2032
    Image for Predictive Maintenance Market 2025-2032: Industry Outlook, Trends Analysis, New Opportunities, and Prospects
    Predictive Maintenance Market 2025-2032: Industry Outlook, Trends Analysis, New Opportunities, and Prospects
    Image for Oilseed Market to Expand at a CAGR of 5.3% by 2032 – Growth Drivers & Forecast Analysis
    Oilseed Market to Expand at a Cagr of 5.3% by 2032 – Growth Drivers & Forecast Analysis
    Image for Offshore Decommissioning Market Predicted to Reach USD 12.27 Billion by 2032, Growing at a CAGR of 6.3% | Coherent Market Insights
    Offshore Decommissioning Market Predicted to Reach Usd 12.27 Billion by 2032, Growing at a Cagr of 6.3% | Coherent Market Insights
    Image for Flea And Tick Products Market Anticipated to flourish at a CAGR of 9.32% from 2025 to 2032
    Flea and Tick Products Market Anticipated to Flourish at a Cagr of 9.32% From 2025 to 2032
    Image for Customer Data Platform Market Growth Probability, Key Vendors and Future Scenario Up To 2032
    Customer Data Platform Market Growth Probability, Key Vendors and Future Scenario up to 2032
    Image for Carbon Dioxide Utilization Market to Hit $14.38 Bn by 2032 with a CAGR of 13.6% According to Coherent Market Insights
    Carbon Dioxide Utilization Market to Hit $14.38 Bn by 2032 With a Cagr of 13.6% According to Coherent Market Insights
    Image for Beauty Supplements Market Anticipated to flourish at a CAGR of 5.55% from 2025 to 2032, reaching USD 4,591 Million by 2032
    Beauty Supplements Market Anticipated to Flourish at a Cagr of 5.55% From 2025 to 2032, Reaching Usd 4,591 Million by 2032
    Image for AI Governance Market Size & Forecast 2025-2032 : Emerging Business Opportunities and Growth Prospects
    AI Governance Market Size & Forecast 2025-2032 : Emerging Business Opportunities and Growth Prospects
    Image for Wireline Services Market to Reach USD 47.13 Billion by 2032 with a 7.0% CAGR According to Coherent Market Insights
    Wireline Services Market to Reach Usd 47.13 Billion by 2032 With a 7.0% Cagr According to Coherent Market Insights
    Image for U.S. Hospitality Staffing Market to be Worth USD 258.72 Billion by 2032: Coherent Market Insights
    U.S. Hospitality Staffing Market to Be Worth Usd 258.72 Billion by 2032: Coherent Market Insights
    View All Research Reports Posts
    Previous Research Reports PostInfusion Pumps Market Was Valued at Us$ 747.0 Mn in 2020 and Is Expected to Exhibit a Cagr of 4.8% During the Forecast Period.
    Next Research Reports PostRice Syrup Market 2021: Business Prospects, Forthcoming Developments and Future Investments to 2028